| Literature DB >> 34616364 |
Vipula Kolli1, Isabela Werneck da Cunha2, SunA Kim2, James R Iben3, Ashwini Mallappa1, Tianwei Li3, Alison Gaynor1, Steven L Coon3, Martha M Quezado2, Deborah P Merke1,3.
Abstract
Introduction: Adrenocortical hyperplasia and adrenal rest tumor (ART) formation are common in congenital adrenal hyperplasia (CAH). Although driven by excessive corticotropin, much is unknown regarding the morphology and transformation of these tissues. Our study objective was to characterize CAH-affected adrenals and ART and compare with control adrenal and gonadal tissues. Patients/Entities:
Keywords: adrenal insufficiency; congenital adrenal hyperplasia; para-ovarian adrenal rest tissue; principal component analysis; testicular adrenal rest tissue
Mesh:
Substances:
Year: 2021 PMID: 34616364 PMCID: PMC8488225 DOI: 10.3389/fendo.2021.730947
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Clinical, genetic and radiological findings of six patients with adrenal and/or adrenal rest masses.
| Patient No. | CAH-1 | CAH-2 | CAH-3 | CAH-4 | CAH-5 | CAH-6 | |
|---|---|---|---|---|---|---|---|
| Sex | F | F | F | F | M | F | |
| Age at CAH presentation | Birth | 8 days | 2 years | 6 weeks | 3.6 years | Birth | |
| CAH type | 21-OHD (32) | 21-OHD (12) | 21-OHD (33) | 21-OHD | P450scc Deficiency (34) | 21-OHD | |
| Genotype | intron 2 IVS2-13A/C>G/p.R483P | homozygous exon 6 cluster: p.I236N, p.V237E, p.M239K | p.I172N/30 kb deletion | 30kb deletion/30kb deletion | I279Yfs*10/p.E314K | intron 2 IVS2-13A/C>G/30 kb deletion | |
| Phenotype | SV | SW | SV | SW | NC | SV | |
| Sample tissue | Adrenal | Adrenal, Para-OART | Adrenal | Adrenal | TART | Adrenal | |
| Radiology findings prior to surgery | CT adrenals: lobulated, enhanced L adrenal mass measuring 10 x 3 x 7 cm compressing the L kidney | CT adrenals (at age 16): markedly enlarged bilateral adrenals | CT adrenals: bilateral moderately hyperplastic adrenals with a L adrenal gland nodule | CT adrenals: Three masses from L adrenal, largest 6.2 x 1.5 cm and R adrenal mass arising from the medial limb measuring 1.9 x 1.8 cm - bilateral adrenal masses suggestive of myelolipoma | Scrotal U/s (at age 16): R testis measured 4.5 x 2 cm with three hypoechoic lesions measuring 2.1 x 1.0 cm, 1.2 x 1.0 cm, 0.4 x 0.3 cm. | CT adrenals: Fat containing complex L adrenal mass measuring 13 x 12 x 11 cm suggestive of myelolipoma. L kidney displaced inferiorly | |
| 18F-PET/CT with Cosyntropin 250 µg injection | L testis measured 4.3 x 2.7 cm - two hypoechoic lesions: 2.0 x 1.0 cm, 1.3 x 1.0 cm with diffuse peripheral calcification | ||||||
| (at age 32): three areas of active uptake near both ovaries | |||||||
| Indication for surgery | Abdominal pain secondary to large L sided adrenal mass | Virilization with primary amenorrhea at age 16, had marked adrenal enlargement and underwent bilateral adrenalectomy at age 17. At age 32 presented with hyperandrogenism. Workup consistent with ectopic adrenal rest tumors near the ovaries | Poor disease control with secondary amenorrhea and patient desired fertility | Incidentally identified adrenal masses for work up chronic lower abdominal pain | Incidentally identified testicular mass of unknown etiology (prior to CAH diagnosis) | Abdominal pain secondary to large L sided adrenal mass R adrenal – bilateral flank pain and hematuria | |
| Age at surgery (years) | 29 | 32 | 21 | 58 | 17 | 42 | |
| Surgical procedure | L-sided adrenalectomy | Bilateral adrenalectomy, excision of paraovarian adrenal rest tumors | Bilateral adrenalectomy | L-sided adrenalectomy | L testicular exploration with tumor enucleation | Bilateral adrenalectomy | |
| Medications At Surgery | Glucocorticoid¥ equivalent- dose (mg/day) | None- was off meds for 13 years | 30# | 40$ | 15 Ω | 12.5 | 40* |
| Fludrocortisone (µg/day) | 100 | 150 | None | 100 | 150 | ||
F, female; M, male; CAH, congenital adrenal hyperplasia; 21-OHD, 21-hydroxylase deficiency; P450scc, cytochrome P450 side chain cleavage; kb, kilobase; SV, simple-virilizing; SW, salt-wasting; NC, non-classic; CT, computed tomography; L, left; 18F-FDG PET, 18F-fluorodeoxyglucose positron emission tomography; U/s, ultrasound; R, right.
¥Glucocorticoid-equivalent dose, hydrocortisone x 1, and dexamethasone x 80;
#dexamethasone 0.375 mg once daily;
$dexamethasone 0.25 mg twice daily;
*dexamethasone 0.5 mg once daily;
Ωhydrocortisone twice daily.
Figure 1Histological comparison of adrenal rest tumor tissue (ART) and adrenal glands from CAH patients. Hematoxylin and eosin (H&E) staining with low power (40X) observation of control adrenal, CAH adrenal and ARTs shows: control adrenal glands with clear zonation including distinct cortical (C) and medullary areas (M), CAH adrenal with hyperplastic adrenocortical cells and no clear zonation, testicular adrenal rest tissue (TART) consisting of eosinophilic epithelioid cells with abundant cytoplasm and testicular seminiferous tubules (T) in the periphery and para-ovarian adrenal rest tissue (Para-OART) cells with large nuclei and with lymphoid aggregates in between (arrows). Immunohistochemistry images show positive staining for adrenal- MC2R (adrenocorticotrophic hormone receptor: ACTHR) and DLK1 (delta like non-canonical notch ligand 1) protein expression in control adrenal, CAH adrenal (representative sample) and also in adrenal rest tissue (Original magnification X40 for MC2R and X100 for DLK1).
Figure 2Steroidogenic immunolabeling in control and CAH adrenals,TART and para-OART. Immunohistochemical staining of control adrenal shows positive staining for all three zone-characteristic proteins. ART and representative CAH adrenals display strong staining of zona reticularis-characteristic CYB5A, a marker of androgen production, positive staining but less presence of CYP11B1, and negative staining for CYP11B2 proteins. Two of five CAH adrenals had minimal CYP11B2 staining (not shown). Interstitial/vascular spaces with fibroblasts, vessels and other structures are negatively stained. (Original magnification X400).
Figure 3Immunohistochemical staining for mono nuclear cell infiltration, labeling with CD20, CD3, CD68 in control and, CAH adrenals and TART and Para-OART. Immunohistochemical staining of ART and CAH adrenals with lymphocytic markers CD20 (B-lymphocytes), CD3 (T-lymphocytes) and CD68 (histiocytes) displays an elevated expression in lymphocytic aggregates in the adrenal parenchyma in CAH adrenals and nodular lymphocytic aggregates in para-OART (arrows). CD68 shows scattered histiocytes through the cortex or within the cortical cells (Original magnification X100).
Figure 4Heatmap illustrating differential RNA-seq expression data in ART, CAH adrenals and control tissues. Heatmap showing relative log-transformed expression levels of (A) adrenal enriched- (DLK1, MC2R, TSPAN12, SULTA1), gonadal enriched- (FATE1, HSD17B3, INSL3) markers, and (B) genes specific to inflammation and immune response (IL18, IRF8, CD68, IL17RA, TLR4, CXCL12). Red color indicates relatively higher number of transcripts and blue color indicates relatively lower number of transcripts based on normalized read counts.
Figure 5Hierarchical clustering and principle component analysis of ART, CAH adrenals and control tissues. (A) Heatmap of unsupervised clustering of the samples showing the top 500 most- variable genes, and (B) Principal Component Analysis (PCA) showing the correlation between the samples.